Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.16 | 2.04% | 0.00 |
TNXP closed up 2.04 percent on Wednesday, April 24, 2024, on 39 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| NR7 | Range Contraction | 2.04% | |
| Narrow Range Bar | Range Contraction | 2.04% | |
| Wide Bands | Range Expansion | 2.04% | |
| Inside Day | Range Contraction | 2.96% | |
| Wide Bands | Range Expansion | 2.96% |
| Alert | Time |
|---|---|
| Possible NR7 | about 8 hours ago |
| Possible Inside Day | about 8 hours ago |
| 60 Minute Opening Range Breakdown | about 11 hours ago |
| Down 1% | about 12 hours ago |
| 10 DMA Resistance | about 12 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.3119 |
| 52 Week Low | 0.1202 |
| Average Volume | 2,512,990 |
| 200-Day Moving Average | 0.60 |
| 50-Day Moving Average | 0.28 |
| 20-Day Moving Average | 0.18 |
| 10-Day Moving Average | 0.16 |
| Average True Range | 0.02 |
| RSI (14) | 31.03 |
| ADX | 47.0 |
| +DI | 9.26 |
| -DI | 31.70 |
| Chandelier Exit (Long, 3 ATRs) | 0.29 |
| Chandelier Exit (Short, 3 ATRs) | 0.19 |
| Upper Bollinger Bands | 0.25 |
| Lower Bollinger Band | 0.10 |
| Percent B (%b) | 0.37 |
| BandWidth | 83.22 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.04 |
| MACD Histogram | 0.0039 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.17 | ||||
| Resistance 3 (R3) | 0.17 | 0.16 | 0.17 | ||
| Resistance 2 (R2) | 0.16 | 0.16 | 0.16 | 0.17 | |
| Resistance 1 (R1) | 0.16 | 0.16 | 0.16 | 0.16 | 0.17 |
| Pivot Point | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Support 1 (S1) | 0.16 | 0.16 | 0.16 | 0.16 | 0.15 |
| Support 2 (S2) | 0.15 | 0.16 | 0.15 | 0.15 | |
| Support 3 (S3) | 0.15 | 0.15 | 0.15 | ||
| Support 4 (S4) | 0.15 |
